儿童肺高血压药物的先前授权负担:量化评估
Delphine Yung1,2, Anne Davis1, Kelly Merrill1
1Seattle Children's Hospital Seattle Washington USA.
Pulmonary circulation
|December 15, 2025
概括
预先授权 (PA) 显著加重儿科肺高血压 (PH) 护理的负担,导致延迟和行政工作,尽管批准率高. 政策改革是必要的,以便及时获得必要的PH治疗.
科学领域:
- 儿科肺病学 儿科肺病学
- 医疗保健服务研究 医疗服务研究
- 卫生政策 卫生政策
背景情况:
- 预先授权 (PA) 是药物批准的保险要求.
- 儿科肺高血压 (PH) 需要复杂的,通常是长期的治疗.
- 在儿科PH中PA的行政负担没有得到很好的量化.
研究的目的:
- 量化对儿科肺高血压 (PH) 药物事先授权 (PA) 的负担.
- 分析PA对治疗准入和行政工作量的影响.
- 确定在儿科PH药物治疗中政策改进的领域.
主要方法:
- 对53名儿科PH患者的283份处方进行了回顾性分析.
- 数据是从2021-2023年在一个认可的PH中心收集的.
- 量化PA要求,批准率,延误和行政挑战.
主要成果:
- 72%的处方需要事先授权 (PA).
- 非FDA批准的药物具有最高的PA体积.
- 尽管获得了97%的批准,但平均延误为4.2天,其中39%需要重复请求.
结论:
- 预先授权 (PA) 对儿科肺高血压 (PH) 护理造成了重大行政负担.
- 与PA相关的延迟和行政复杂性阻碍了及时获得必要的PH疗法.
- 政策改革至关重要,以简化PA流程,确保公平获得儿科PH药物.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Pharmacokinetics in Pediatric Patients: Drug Distribution
240
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
424
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
424
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169


